Sonen Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$279K Sell
1,777
-539
-23% -$82.6K 0.53% 56
2023
Q3
$361K Sell
2,316
-232
-9% -$38.3K 0.71% 53
2023
Q2
$422K Buy
2,548
+1,040
+69% +$168K 0.7% 48
2023
Q1
$234K Sell
1,508
-829
-35% -$134K 0.4% 85
2022
Q4
$413K Sell
2,337
-105
-4% -$18.1K 0.68% 66
2022
Q3
$399K Sell
2,442
-264
-10% -$44.7K 0.65% 75
2022
Q2
$480K Buy
2,706
+275
+11% +$49K 0.69% 56
2022
Q1
$431K Sell
2,431
-138
-5% -$23.5K 0.52% 69
2021
Q4
$439K Buy
+2,569
New +$421K 0.42% 78

Other funds holding JNJ

Sonen Capital's JNJ Position: Q4 2023 in Review

Sonen Capital reduced its Johnson & Johnson (JNJ) stake by 23% in Q4 2023, selling an estimated $82.6K and leaving 1,777 shares worth $279K. The position accounts for 0.53% of the portfolio, ranked #56.

Sonen Capital first reported a position in JNJ in Q4 2021 and has held it in 9 quarters since. The position peaked at $480K in Q2 2022. 3,868 funds tracked by Wall St. Rank hold JNJ as of Q4 2023.

  • Sonen Capital held 1,777 shares of Johnson & Johnson worth $279K as of Q4 2023.
  • Sonen Capital sold 539 Johnson & Johnson shares in Q4 2023, an estimated $82.6K.
  • Johnson & Johnson made up 0.53% of Sonen Capital's portfolio in Q4 2023, its #56 holding.
  • Sonen Capital first reported a position in Johnson & Johnson in Q4 2021 and has held it in 9 quarters since.
  • Sonen Capital's Johnson & Johnson position peaked at $480K in Q2 2022.
  • 3,868 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2023.

Based on Sonen Capital's 13F filing for Q4 2023, filed 2 Feb 2024.